CHARLES RIVER LABORATORIES
CRLNYSE🏆 #650 by market capEarnings Nov 4US Equity
$282.84▲ $0.85 (+0.30%)
Live1h▲ 0.3%
24h▲ 0.3%
7d▲ 8.5%
14d▲ 20.4%
30d▲ 23.1%
1y▲ 85.1%
🏦Market Cap
$13.62B
Mid Cap
📈Revenue Growth (YoY)
-0.8%
Declining
📊Gross Margin
32.2%
Moderate
💵FCF Margin
9.3%
Moderate
⚖️P/S Ratio
3.4x
Fair
Otter Score
47
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
3.02
Expected
2.77
beat
+9.00%
YoY −3.20%
Revenue
Actual
$1.00B
Expected
$980.53M
beat
+2.40%
YoY −2.70%
Consensus estimates
Recent quarters
Q3 2026
3.02
beat
Q2 2026
2.06
beat
Q1 2026
2.39
beat
Q4 2025
2.43
beat